Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development-Reference-Cited by-同舟云学术

Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development

Published:2021 Issue: Volume: Page:197-220
ISSN:0171-2004
Container-title:The Kappa Opioid Receptor
language:
Short-container-title:

Author:

Aldrich Jane V.,McLaughlin Jay P.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/164_2021_519

Reference106 articles.

1. Albert-Vartanian A, Boyd MR, Hall AL, Morgado SJ, Nguyen E et al (2016) Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther 41:371–382. https://doi.org/10.1111/jcpt.12404

2. Aldrich JV, McLaughlin JP (2009) Peptide kappa opioid receptor ligands: potential for drug development. AAPS J 11:312–322. https://doi.org/10.1208/s12248-009-9105-4

3. Aldrich JV, Vigil-Cruz SC (2003) Narcotic analgesics. In: Abraham DJ (ed) Burger’s medicinal chemistry & drug discovery, 6th edn. Wiley, New York, pp 329–481

4. Aldrich JV, Patkar KA, McLaughlin JP (2009) Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc Natl Acad Sci U S A 106:18396–18401. https://doi.org/10.1073/pnas.0910180106

5. Aldrich JV, Kulkarni SS, Senadheera SN, Ross NC, Reilley KJ et al (2011) Unexpected opioid activity profiles of analogs of the novel peptide kappa opioid receptor ligand CJ-15,208. ChemMedChem 6:1739–1745. https://doi.org/10.1002/cmdc.201100113

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator;ACS Pharmacology & Translational Science;2024-09-11

2. Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening;Journal of Medicinal Chemistry;2024-08-01

3. A Bicyclic Analog of the Linear Peptide Arodyn Is a Potent and Selective Kappa Opioid Receptor Antagonist;Molecules;2024-06-29

4. Model informed drug development: HSK21542 PBPK model supporting dose decisions in specific populations;European Journal of Pharmaceutical Sciences;2024-05

5. Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples;Journal of Medicinal Chemistry;2023-08-26